Cardiac magnetic resonance (CMR) it is a technique without radiation, which is considered the gold-standard for the evaluation of cardiac anatomy, function and even tissue composition. The RESILIENCE trial will use CMR as the main outcome measure methodology, and patients enrolled in the trial will undergo 3 scans across the duration of the study.
Multinational, prospective, proof of concept phase II, double-blinded, sham-controlled, randomized clinical trial (RCT) to evaluate the efficacy and safety of Remote Ischaemic Conditioning (RIC) in Lymphoma patients receiving anthracyclines. Patients scheduled to undergo ≥5 chemotherapy cycles will be eligible.
Cardiotoxicity is an alteration in the function of the heart muscle caused by certain cancer treatments, especially antineoplastic drugs such as anthracyclines. This dysfunction can progress to heart failure, one of the most serious complications in cancer patients. In the early stages, we speak of subclinical or preclinical cardiotoxicity, when the damage has not yet […]
